Nuvectis Pharma's total assets for Q3 2025 were $35.59M, an increase of 31.77% from the previous quarter. NVCT total liabilities were $11.58M for the fiscal quarter, a 14.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.